Eliminating Mother-to-Child Transmission of Viral Hepatitis B in Vietnam

Co-funded with Ville de Genève. 

GEOGRAPHIC REACH  Asia/Vietnam
PARTNER PATH, in collaboration with Nghe An Province CDC  – Co-funded with the Ville de Genève.

CONTEXT

Mothers who are infected with hepatitis B virus (HBV), HIV, or syphilis can pass these viruses to their babies during pregnancy, childbirth, or while breastfeeding—called mother-to-child transmission.. Every year, more than 180,000 newborns in the Asia-Pacific region become newly infected with HBV. Vietnam is among the countries with a high prevalence of HBV worldwide (8.1%). Since 2019, the country has endorsed the World Health Organization’s global triple elimination initiative, which seeks to eliminate mother-to-child transmission (EMTCT) for HBV, HIV, and syphilis.

THE PROGRAMME   

With support from the City of Geneva and The Hepatitis Fund, PATH, in collaboration with Nghe An Center for Disease Control (CDC), deployed a decentralized, integrated, and coordinated model of combined universal screening for HBV, HIV, and syphilis in Nghe An—Vietnam’s largest province by area, with a total population of more than 3.5 million people. 

The three-year programme, launched in 2022, is currently being implemented at commune health stations, private health facilities, and district hospitals in two districts of Nghe An, where uptake of HBV, HIV, and syphilis testing among pregnant women is low.

EXPECTED RESULTS

The project will provide a hepatitis-free future to newborn babies in Nghe An, which is Vietnam’s largest province, located in the North Central Coast region of the country, with 3,547,247 people living in 21 districts. 

The project will aim to screen 90% of pregnant women receiving antenatal care, treat 80% of eligible pregnant women with Tenofovir (TDF) prophylaxis or treatment, and vaccinate up to 98% of newborns with the HBV birth dose vaccine at the project sites by the end of the project life. 

Evidence generated from implementing the triple EMTCT model in Nghe An will be used to establish a comprehensive evidence base to advocate for financing and programming toward universal access to HBV, HIV, and syphilis screening and care. This includes integrating HBV, HIV, and syphilis screening as a core part of Vietnam’s MNCH and primary health care services and ensuring its coverage in social health insurance structures.

Grant USD 327,000 for three years.

Read about our other grants.